Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/49071
Title: Association of the CYP2C19 *2 allele on the occurrence of in-stent restenosis in patients undergoing coronary stenting
Authors: Wirth, Francesca
Zahra, Graziella
Xuereb, Robert G.
Barbara, Christopher
Fenech, Albert
Azzopardi, Lilian M.
Keywords: Clopidogrel
Coronary arteries -- Stenosis -- Malta
Coronary heart disease -- Chemotherapy
Stents (Surgery)
Issue Date: 2015-06
Publisher: University of Malta. Department of Pharmacy
Citation: Wirth, F., Zahra, G., Xuereb, R. G., Barbara, C., Fenech, A., & Azzopardi, L. M. (2015, June). Association of the CYP2C19 *2 allele on the occurrence of in-stent restenosis in patients undergoing coronary stenting. Poster session presented at the Nordic Social Pharmacy and Health Services Research Conference & The Nordic Networking Group for Clinical Pharmacy, Tartu, Estonia.
Abstract: A poster presentation regarding the association of the CYP2C19 *2 allele on the occurrence of in-stent restenosis in patients undergoing coronary stenting. Background: Proper functioning of the CYP2C19 enzyme is required to convert clopidogrel to its active metabolites to be able to exert its antiplatelet effect. Presence of the CYP2C19 loss-of-function (LoF) *2 variant allele is associated with a decreased response to clopidogrel which may lead to adverse cardiac events post-percutaneous coronary intervention (PCI). Objectives: To genotype patients undergoing PCI for carriage of the CYP2C19 LoF *2 allele and to analyse whether there is an association between presence of the LoF allele and occurrence of in-stent restenosis (ISR) in these patients.
URI: https://www.um.edu.mt/library/oar/handle/123456789/49071
Appears in Collections:Scholarly Works - FacM&SPha



Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.